タグリッソ（オシメルチニブ）のグローバル市場インサイト・予測（～2028年）

• 英文タイトル：Global Tagrisso (Osimertinib) Market Insights, Forecast to 2028

• レポートコード：QY2207E10495 • 出版社/出版日：QYResearch / 2022年7月 • レポート形態：英文、PDF、86ページ • 納品方法：Eメール（納期：3日） • 産業分類：医薬品

• 販売価格（消費税別）

Single User	￥725,200 (USD4,900)	▷ お問い合わせ
Multi User	￥1,087,800 (USD7,350)	▷ お問い合わせ
Enterprise License	￥1,450,400 (USD9,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

新型コロナウイルス感染症のパンデミックにより、世界のタグリッソ（オシメルチニブ）の市場規模は2022年にUS$xxxと推定され、調査期間中のCAGRはxxx％で、2028年までに再調整された規模はUS$xxxになると予測されています。この医療危機による経済変化を十分に考慮すると、2021年にタグリッソ（オシメルチニブ）の世界市場のxxx％を占める「40mg」タイプは、2028年までにUS$xxxの規模になり、パンデミック後の修正xxx％CAGRで成長すると予測されています。一方、「局所進行性非小細胞肺癌」セグメントは、この予測期間を通じてxxx％のCAGRに変更されます。 中国のタグリッソ（オシメルチニブ）の市場規模は2021年にUS$xxxと分析されており、米国とヨーロッパのタグリッソ（オシメルチニブ）市場規模はそれぞれUS$xxxとUS$xxxです。米国の割合は2021年にxxx％であり、中国とヨーロッパはそれぞれxxx％とxxx％です。中国の割合は2028年にxxx％に達し、対象期間を通じてxxx％のCAGRを記録すると予測されています。日本、韓国、東南アジアはアジアで注目市場であり、今後6年間のCAGRはそれぞれxxx％、xxx％、xxx％になる見通しです。ヨーロッパのタグリッソ（オシメルチニブ）市場については、ドイツは2028年までにUS$xxxに達すると予測されており、予測期間中のCAGRはxxx％になる見通しです。 タグリッソ（オシメルチニブ）のグローバル主要メーカーには、AstraZeneca、Incepta Pharmaceuticals Ltd、Lonza AG、Everest Pharmaceuticals、Beacon Pharmaceuticals Limited、Drug International Limitedなどがあります。2021年、世界のトップ5プレイヤーは売上ベースで約xxx％の市場シェアを占めています。 タグリッソ（オシメルチニブ）市場は、種類と用途によって区分されます。世界のタグリッソ（オシメルチニブ）市場のプレーヤー、利害関係者、およびその他の参加者は、当レポートを有益なリソースとして使用することで優位に立つことができます。セグメント分析は、2017年～2028年期間のタイプ別および用途別の販売量、売上、予測に焦点を当てています。 【種類別セグメント】 40mg、80mg 【用途別セグメント】 局所進行性非小細胞肺癌、転移性非小細胞肺癌、その他 【掲載地域】 北米：アメリカ、カナダ ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア アジア太平洋：日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア 中南米：メキシコ、ブラジル、アルゼンチン 中東・アフリカ：トルコ、サウジアラビア、UAE 【目次（一部）】 ・調査の範囲 - タグリッソ（オシメルチニブ）製品概要 - 種類別市場（40mg、80mg） - 用途別市場（局所進行性非小細胞肺癌、転移性非小細胞肺癌、その他） - 調査の目的 ・エグゼクティブサマリー - 世界のタグリッソ（オシメルチニブ）販売量予測2017-2028 - 世界のタグリッソ（オシメルチニブ）売上予測2017-2028 - タグリッソ（オシメルチニブ）の地域別販売量 - タグリッソ（オシメルチニブ）の地域別売上 - 北米市場 - ヨーロッパ市場 - アジア太平洋市場 - 中南米市場 - 中東・アフリカ市場 ・メーカーの競争状況 - 主要メーカー別タグリッソ（オシメルチニブ）販売量 - 主要メーカー別タグリッソ（オシメルチニブ）売上 - 主要メーカー別タグリッソ（オシメルチニブ）価格 - 競争状況の分析 - 企業M&A動向 ・種類別市場規模（40mg、80mg） - タグリッソ（オシメルチニブ）の種類別販売量 - タグリッソ（オシメルチニブ）の種類別売上 - タグリッソ（オシメルチニブ）の種類別価格 ・用途別市場規模（局所進行性非小細胞肺癌、転移性非小細胞肺癌、その他） - タグリッソ（オシメルチニブ）の用途別販売量 - タグリッソ（オシメルチニブ）の用途別売上 - タグリッソ（オシメルチニブ）の用途別価格 ・北米市場 - 北米のタグリッソ（オシメルチニブ）市場規模（種類別、用途別） - 主要国別のタグリッソ（オシメルチニブ）市場規模（アメリカ、カナダ） ・ヨーロッパ市場 - ヨーロッパのタグリッソ（オシメルチニブ）市場規模（種類別、用途別） - 主要国別のタグリッソ（オシメルチニブ）市場規模（ドイツ、フランス、イギリス、イタリア、ロシア） ・アジア太平洋市場 - アジア太平洋のタグリッソ（オシメルチニブ）市場規模（種類別、用途別） - 主要国別のタグリッソ（オシメルチニブ）市場規模（日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア） ・中南米市場 - 中南米のタグリッソ（オシメルチニブ）市場規模（種類別、用途別） - 主要国別のタグリッソ（オシメルチニブ）市場規模（メキシコ、ブラジル、アルゼンチン） ・中東・アフリカ市場 - 中東・アフリカのタグリッソ（オシメルチニブ）市場規模（種類別、用途別） - 主要国別のタグリッソ（オシメルチニブ）市場規模（トルコ、サウジアラビア） ・企業情報 AstraZeneca、Incepta Pharmaceuticals Ltd、Lonza AG、Everest Pharmaceuticals、Beacon Pharmaceuticals Limited、Drug International Limited ・産業チェーン及び販売チャネル分析 - タグリッソ（オシメルチニブ）の産業チェーン分析 - タグリッソ（オシメルチニブ）の原材料 - タグリッソ（オシメルチニブ）の生産プロセス - タグリッソ（オシメルチニブ）の販売及びマーケティング - タグリッソ（オシメルチニブ）の主要顧客 ・マーケットドライバー、機会、課題、リスク要因分析 - タグリッソ（オシメルチニブ）の産業動向 - タグリッソ（オシメルチニブ）のマーケットドライバー - タグリッソ（オシメルチニブ）の課題 - タグリッソ（オシメルチニブ）の阻害要因 ・主な調査結果

Market Analysis and Insights: Global Tagrisso (Osimertinib) Market
Due to the COVID-19 pandemic, the global Tagrisso (Osimertinib) market size is estimated to be worth US$ million in 2022 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the forecast period 2022-2028. Fully considering the economic change by this health crisis, 40 mg accounting for % of the Tagrisso (Osimertinib) global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR from 2022 to 2028. While Locally Advanced NSCLC segment is altered to an % CAGR throughout this forecast period.
China Tagrisso (Osimertinib) market size is valued at US$ million in 2021, while the US and Europe Tagrisso (Osimertinib) are US$ million and US$ million, severally. The proportion of the US is % in 2021, while China and Europe are % and % respectively, and it is predicted that China proportion will reach % in 2028, trailing a CAGR of % through the analysis period 2022-2028. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR %, %, and % respectively for the next 6-year period. As for the Europe Tagrisso (Osimertinib) landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period 2022-2028.
The global key manufacturers of Tagrisso (Osimertinib) include AstraZeneca, Incepta Pharmaceuticals Ltd, Lonza AG, Everest Pharmaceuticals, Beacon Pharmaceuticals Limited and Drug International Limited, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
Global Tagrisso (Osimertinib) Scope and Segment
Tagrisso (Osimertinib) market is segmented by Type and by Application. Players, stakeholders, and other participants in the global Tagrisso (Osimertinib) market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2017-2028.
Segment by Type
40 mg
80 mg
Segment by Application
Locally Advanced NSCLC
Metastatic NSCLC
Other
By Company
AstraZeneca
Incepta Pharmaceuticals Ltd
Lonza AG
Everest Pharmaceuticals
Beacon Pharmaceuticals Limited
Drug International Limited
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE

レポート目次

---

1 Study Coverage
1.1 Tagrisso (Osimertinib) Product Introduction
1.2 Market by Type
1.2.1 Global Tagrisso (Osimertinib) Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 40 mg
1.2.3 80 mg
1.3 Market by Application
1.3.1 Global Tagrisso (Osimertinib) Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Locally Advanced NSCLC
1.3.3 Metastatic NSCLC
1.3.4 Other
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Tagrisso (Osimertinib) Sales Estimates and Forecasts 2017-2028
2.2 Global Tagrisso (Osimertinib) Revenue Estimates and Forecasts 2017-2028
2.3 Global Tagrisso (Osimertinib) Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Tagrisso (Osimertinib) Sales by Region
2.4.1 Global Tagrisso (Osimertinib) Sales by Region (2017-2022)
2.4.2 Global Sales Tagrisso (Osimertinib) by Region (2023-2028)
2.5 Global Tagrisso (Osimertinib) Revenue by Region
2.5.1 Global Tagrisso (Osimertinib) Revenue by Region (2017-2022)
2.5.2 Global Tagrisso (Osimertinib) Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Tagrisso (Osimertinib) Sales by Manufacturers
3.1.1 Global Top Tagrisso (Osimertinib) Manufacturers by Sales (2017-2022)
3.1.2 Global Tagrisso (Osimertinib) Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Tagrisso (Osimertinib) in 2021
3.2 Global Tagrisso (Osimertinib) Revenue by Manufacturers
3.2.1 Global Tagrisso (Osimertinib) Revenue by Manufacturers (2017-2022)
3.2.2 Global Tagrisso (Osimertinib) Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Tagrisso (Osimertinib) Revenue in 2021
3.3 Global Tagrisso (Osimertinib) Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Tagrisso (Osimertinib) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Tagrisso (Osimertinib) Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Tagrisso (Osimertinib) Sales by Type
4.1.1 Global Tagrisso (Osimertinib) Historical Sales by Type (2017-2022)
4.1.2 Global Tagrisso (Osimertinib) Forecasted Sales by Type (2023-2028)
4.1.3 Global Tagrisso (Osimertinib) Sales Market Share by Type (2017-2028)
4.2 Global Tagrisso (Osimertinib) Revenue by Type
4.2.1 Global Tagrisso (Osimertinib) Historical Revenue by Type (2017-2022)
4.2.2 Global Tagrisso (Osimertinib) Forecasted Revenue by Type (2023-2028)
4.2.3 Global Tagrisso (Osimertinib) Revenue Market Share by Type (2017-2028)
4.3 Global Tagrisso (Osimertinib) Price by Type
4.3.1 Global Tagrisso (Osimertinib) Price by Type (2017-2022)
4.3.2 Global Tagrisso (Osimertinib) Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Tagrisso (Osimertinib) Sales by Application
5.1.1 Global Tagrisso (Osimertinib) Historical Sales by Application (2017-2022)
5.1.2 Global Tagrisso (Osimertinib) Forecasted Sales by Application (2023-2028)
5.1.3 Global Tagrisso (Osimertinib) Sales Market Share by Application (2017-2028)
5.2 Global Tagrisso (Osimertinib) Revenue by Application
5.2.1 Global Tagrisso (Osimertinib) Historical Revenue by Application (2017-2022)
5.2.2 Global Tagrisso (Osimertinib) Forecasted Revenue by Application (2023-2028)
5.2.3 Global Tagrisso (Osimertinib) Revenue Market Share by Application (2017-2028)
5.3 Global Tagrisso (Osimertinib) Price by Application
5.3.1 Global Tagrisso (Osimertinib) Price by Application (2017-2022)
5.3.2 Global Tagrisso (Osimertinib) Price Forecast by Application (2023-2028)
6 North America
6.1 North America Tagrisso (Osimertinib) Market Size by Type
6.1.1 North America Tagrisso (Osimertinib) Sales by Type (2017-2028)
6.1.2 North America Tagrisso (Osimertinib) Revenue by Type (2017-2028)
6.2 North America Tagrisso (Osimertinib) Market Size by Application
6.2.1 North America Tagrisso (Osimertinib) Sales by Application (2017-2028)
6.2.2 North America Tagrisso (Osimertinib) Revenue by Application (2017-2028)
6.3 North America Tagrisso (Osimertinib) Market Size by Country
6.3.1 North America Tagrisso (Osimertinib) Sales by Country (2017-2028)
6.3.2 North America Tagrisso (Osimertinib) Revenue by Country (2017-2028)
6.3.3 United States
6.3.4 Canada
7 Europe
7.1 Europe Tagrisso (Osimertinib) Market Size by Type
7.1.1 Europe Tagrisso (Osimertinib) Sales by Type (2017-2028)
7.1.2 Europe Tagrisso (Osimertinib) Revenue by Type (2017-2028)
7.2 Europe Tagrisso (Osimertinib) Market Size by Application
7.2.1 Europe Tagrisso (Osimertinib) Sales by Application (2017-2028)
7.2.2 Europe Tagrisso (Osimertinib) Revenue by Application (2017-2028)
7.3 Europe Tagrisso (Osimertinib) Market Size by Country
7.3.1 Europe Tagrisso (Osimertinib) Sales by Country (2017-2028)
7.3.2 Europe Tagrisso (Osimertinib) Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Tagrisso (Osimertinib) Market Size by Type
8.1.1 Asia Pacific Tagrisso (Osimertinib) Sales by Type (2017-2028)
8.1.2 Asia Pacific Tagrisso (Osimertinib) Revenue by Type (2017-2028)
8.2 Asia Pacific Tagrisso (Osimertinib) Market Size by Application
8.2.1 Asia Pacific Tagrisso (Osimertinib) Sales by Application (2017-2028)
8.2.2 Asia Pacific Tagrisso (Osimertinib) Revenue by Application (2017-2028)
8.3 Asia Pacific Tagrisso (Osimertinib) Market Size by Region
8.3.1 Asia Pacific Tagrisso (Osimertinib) Sales by Region (2017-2028)
8.3.2 Asia Pacific Tagrisso (Osimertinib) Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 China Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
9 Latin America
9.1 Latin America Tagrisso (Osimertinib) Market Size by Type
9.1.1 Latin America Tagrisso (Osimertinib) Sales by Type (2017-2028)
9.1.2 Latin America Tagrisso (Osimertinib) Revenue by Type (2017-2028)
9.2 Latin America Tagrisso (Osimertinib) Market Size by Application
9.2.1 Latin America Tagrisso (Osimertinib) Sales by Application (2017-2028)
9.2.2 Latin America Tagrisso (Osimertinib) Revenue by Application (2017-2028)
9.3 Latin America Tagrisso (Osimertinib) Market Size by Country
9.3.1 Latin America Tagrisso (Osimertinib) Sales by Country (2017-2028)
9.3.2 Latin America Tagrisso (Osimertinib) Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
9.3.6 Colombia
10 Middle East and Africa
10.1 Middle East and Africa Tagrisso (Osimertinib) Market Size by Type
10.1.1 Middle East and Africa Tagrisso (Osimertinib) Sales by Type (2017-2028)
10.1.2 Middle East and Africa Tagrisso (Osimertinib) Revenue by Type (2017-2028)
10.2 Middle East and Africa Tagrisso (Osimertinib) Market Size by Application
10.2.1 Middle East and Africa Tagrisso (Osimertinib) Sales by Application (2017-2028)
10.2.2 Middle East and Africa Tagrisso (Osimertinib) Revenue by Application (2017-2028)
10.3 Middle East and Africa Tagrisso (Osimertinib) Market Size by Country
10.3.1 Middle East and Africa Tagrisso (Osimertinib) Sales by Country (2017-2028)
10.3.2 Middle East and Africa Tagrisso (Osimertinib) Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 AstraZeneca
11.1.1 AstraZeneca Corporation Information
11.1.2 AstraZeneca Overview
11.1.3 AstraZeneca Tagrisso (Osimertinib) Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 AstraZeneca Tagrisso (Osimertinib) Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 AstraZeneca Recent Developments
11.2 Incepta Pharmaceuticals Ltd
11.2.1 Incepta Pharmaceuticals Ltd Corporation Information
11.2.2 Incepta Pharmaceuticals Ltd Overview
11.2.3 Incepta Pharmaceuticals Ltd Tagrisso (Osimertinib) Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 Incepta Pharmaceuticals Ltd Tagrisso (Osimertinib) Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Incepta Pharmaceuticals Ltd Recent Developments
11.3 Lonza AG
11.3.1 Lonza AG Corporation Information
11.3.2 Lonza AG Overview
11.3.3 Lonza AG Tagrisso (Osimertinib) Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 Lonza AG Tagrisso (Osimertinib) Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Lonza AG Recent Developments
11.4 Everest Pharmaceuticals
11.4.1 Everest Pharmaceuticals Corporation Information
11.4.2 Everest Pharmaceuticals Overview
11.4.3 Everest Pharmaceuticals Tagrisso (Osimertinib) Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 Everest Pharmaceuticals Tagrisso (Osimertinib) Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Everest Pharmaceuticals Recent Developments
11.5 Beacon Pharmaceuticals Limited
11.5.1 Beacon Pharmaceuticals Limited Corporation Information
11.5.2 Beacon Pharmaceuticals Limited Overview
11.5.3 Beacon Pharmaceuticals Limited Tagrisso (Osimertinib) Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 Beacon Pharmaceuticals Limited Tagrisso (Osimertinib) Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Beacon Pharmaceuticals Limited Recent Developments
11.6 Drug International Limited
11.6.1 Drug International Limited Corporation Information
11.6.2 Drug International Limited Overview
11.6.3 Drug International Limited Tagrisso (Osimertinib) Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 Drug International Limited Tagrisso (Osimertinib) Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Drug International Limited Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Tagrisso (Osimertinib) Industry Chain Analysis
12.2 Tagrisso (Osimertinib) Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Tagrisso (Osimertinib) Production Mode & Process
12.4 Tagrisso (Osimertinib) Sales and Marketing
12.4.1 Tagrisso (Osimertinib) Sales Channels
12.4.2 Tagrisso (Osimertinib) Distributors
12.5 Tagrisso (Osimertinib) Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Tagrisso (Osimertinib) Industry Trends
13.2 Tagrisso (Osimertinib) Market Drivers
13.3 Tagrisso (Osimertinib) Market Challenges
13.4 Tagrisso (Osimertinib) Market Restraints
14 Key Findings in The Global Tagrisso (Osimertinib) Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

List of Tables
Table 1. Global Tagrisso (Osimertinib) Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
Table 2. Major Manufacturers of 40 mg
Table 3. Major Manufacturers of 80 mg
Table 4. Global Tagrisso (Osimertinib) Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
Table 5. Global Tagrisso (Osimertinib) Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
Table 6. Global Tagrisso (Osimertinib) Sales by Region (2017-2022) & (K Pcs)
Table 7. Global Tagrisso (Osimertinib) Sales Market Share by Region (2017-2022)
Table 8. Global Tagrisso (Osimertinib) Sales by Region (2023-2028) & (K Pcs)
Table 9. Global Tagrisso (Osimertinib) Sales Market Share by Region (2023-2028)
Table 10. Global Tagrisso (Osimertinib) Revenue by Region (2017-2022) & (US$ Million)
Table 11. Global Tagrisso (Osimertinib) Revenue Market Share by Region (2017-2022)
Table 12. Global Tagrisso (Osimertinib) Revenue by Region (2023-2028) & (US$ Million)
Table 13. Global Tagrisso (Osimertinib) Revenue Market Share by Region (2023-2028)
Table 14. Global Tagrisso (Osimertinib) Sales by Manufacturers (2017-2022) & (K Pcs)
Table 15. Global Tagrisso (Osimertinib) Sales Share by Manufacturers (2017-2022)
Table 16. Global Tagrisso (Osimertinib) Revenue by Manufacturers (2017-2022) & (US$ Million)
Table 17. Global Tagrisso (Osimertinib) Revenue Share by Manufacturers (2017-2022)
Table 18. Tagrisso (Osimertinib) Price by Manufacturers (2017-2022) &(US$/Pcs)
Table 19. Global Tagrisso (Osimertinib) Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 20. Global Tagrisso (Osimertinib) by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Tagrisso (Osimertinib) as of 2021)
Table 21. Tagrisso (Osimertinib) Manufacturing Base Distribution and Headquarters
Table 22. Manufacturers Tagrisso (Osimertinib) Product Offered
Table 23. Date of Manufacturers Enter into Tagrisso (Osimertinib) Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Tagrisso (Osimertinib) Sales by Type (2017-2022) & (K Pcs)
Table 26. Global Tagrisso (Osimertinib) Sales by Type (2023-2028) & (K Pcs)
Table 27. Global Tagrisso (Osimertinib) Sales Share by Type (2017-2022)
Table 28. Global Tagrisso (Osimertinib) Sales Share by Type (2023-2028)
Table 29. Global Tagrisso (Osimertinib) Revenue by Type (2017-2022) & (US$ Million)
Table 30. Global Tagrisso (Osimertinib) Revenue by Type (2023-2028) & (US$ Million)
Table 31. Global Tagrisso (Osimertinib) Revenue Share by Type (2017-2022)
Table 32. Global Tagrisso (Osimertinib) Revenue Share by Type (2023-2028)
Table 33. Tagrisso (Osimertinib) Price by Type (2017-2022) & (US$/Pcs)
Table 34. Global Tagrisso (Osimertinib) Price Forecast by Type (2023-2028) & (US$/Pcs)
Table 35. Global Tagrisso (Osimertinib) Sales by Application (2017-2022) & (K Pcs)
Table 36. Global Tagrisso (Osimertinib) Sales by Application (2023-2028) & (K Pcs)
Table 37. Global Tagrisso (Osimertinib) Sales Share by Application (2017-2022)
Table 38. Global Tagrisso (Osimertinib) Sales Share by Application (2023-2028)
Table 39. Global Tagrisso (Osimertinib) Revenue by Application (2017-2022) & (US$ Million)
Table 40. Global Tagrisso (Osimertinib) Revenue by Application (2023-2028) & (US$ Million)
Table 41. Global Tagrisso (Osimertinib) Revenue Share by Application (2017-2022)
Table 42. Global Tagrisso (Osimertinib) Revenue Share by Application (2023-2028)
Table 43. Tagrisso (Osimertinib) Price by Application (2017-2022) & (US$/Pcs)
Table 44. Global Tagrisso (Osimertinib) Price Forecast by Application (2023-2028) & (US$/Pcs)
Table 45. North America Tagrisso (Osimertinib) Sales by Type (2017-2022) & (K Pcs)
Table 46. North America Tagrisso (Osimertinib) Sales by Type (2023-2028) & (K Pcs)
Table 47. North America Tagrisso (Osimertinib) Revenue by Type (2017-2022) & (US$ Million)
Table 48. North America Tagrisso (Osimertinib) Revenue by Type (2023-2028) & (US$ Million)
Table 49. North America Tagrisso (Osimertinib) Sales by Application (2017-2022) & (K Pcs)
Table 50. North America Tagrisso (Osimertinib) Sales by Application (2023-2028) & (K Pcs)
Table 51. North America Tagrisso (Osimertinib) Revenue by Application (2017-2022) & (US$ Million)
Table 52. North America Tagrisso (Osimertinib) Revenue by Application (2023-2028) & (US$ Million)
Table 53. North America Tagrisso (Osimertinib) Sales by Country (2017-2022) & (K Pcs)
Table 54. North America Tagrisso (Osimertinib) Sales by Country (2023-2028) & (K Pcs)
Table 55. North America Tagrisso (Osimertinib) Revenue by Country (2017-2022) & (US$ Million)
Table 56. North America Tagrisso (Osimertinib) Revenue by Country (2023-2028) & (US$ Million)
Table 57. Europe Tagrisso (Osimertinib) Sales by Type (2017-2022) & (K Pcs)
Table 58. Europe Tagrisso (Osimertinib) Sales by Type (2023-2028) & (K Pcs)
Table 59. Europe Tagrisso (Osimertinib) Revenue by Type (2017-2022) & (US$ Million)
Table 60. Europe Tagrisso (Osimertinib) Revenue by Type (2023-2028) & (US$ Million)
Table 61. Europe Tagrisso (Osimertinib) Sales by Application (2017-2022) & (K Pcs)
Table 62. Europe Tagrisso (Osimertinib) Sales by Application (2023-2028) & (K Pcs)
Table 63. Europe Tagrisso (Osimertinib) Revenue by Application (2017-2022) & (US$ Million)
Table 64. Europe Tagrisso (Osimertinib) Revenue by Application (2023-2028) & (US$ Million)
Table 65. Europe Tagrisso (Osimertinib) Sales by Country (2017-2022) & (K Pcs)
Table 66. Europe Tagrisso (Osimertinib) Sales by Country (2023-2028) & (K Pcs)
Table 67. Europe Tagrisso (Osimertinib) Revenue by Country (2017-2022) & (US$ Million)
Table 68. Europe Tagrisso (Osimertinib) Revenue by Country (2023-2028) & (US$ Million)
Table 69. Asia Pacific Tagrisso (Osimertinib) Sales by Type (2017-2022) & (K Pcs)
Table 70. Asia Pacific Tagrisso (Osimertinib) Sales by Type (2023-2028) & (K Pcs)
Table 71. Asia Pacific Tagrisso (Osimertinib) Revenue by Type (2017-2022) & (US$ Million)
Table 72. Asia Pacific Tagrisso (Osimertinib) Revenue by Type (2023-2028) & (US$ Million)
Table 73. Asia Pacific Tagrisso (Osimertinib) Sales by Application (2017-2022) & (K Pcs)
Table 74. Asia Pacific Tagrisso (Osimertinib) Sales by Application (2023-2028) & (K Pcs)
Table 75. Asia Pacific Tagrisso (Osimertinib) Revenue by Application (2017-2022) & (US$ Million)
Table 76. Asia Pacific Tagrisso (Osimertinib) Revenue by Application (2023-2028) & (US$ Million)
Table 77. Asia Pacific Tagrisso (Osimertinib) Sales by Region (2017-2022) & (K Pcs)
Table 78. Asia Pacific Tagrisso (Osimertinib) Sales by Region (2023-2028) & (K Pcs)
Table 79. Asia Pacific Tagrisso (Osimertinib) Revenue by Region (2017-2022) & (US$ Million)
Table 80. Asia Pacific Tagrisso (Osimertinib) Revenue by Region (2023-2028) & (US$ Million)
Table 81. Latin America Tagrisso (Osimertinib) Sales by Type (2017-2022) & (K Pcs)
Table 82. Latin America Tagrisso (Osimertinib) Sales by Type (2023-2028) & (K Pcs)
Table 83. Latin America Tagrisso (Osimertinib) Revenue by Type (2017-2022) & (US$ Million)
Table 84. Latin America Tagrisso (Osimertinib) Revenue by Type (2023-2028) & (US$ Million)
Table 85. Latin America Tagrisso (Osimertinib) Sales by Application (2017-2022) & (K Pcs)
Table 86. Latin America Tagrisso (Osimertinib) Sales by Application (2023-2028) & (K Pcs)
Table 87. Latin America Tagrisso (Osimertinib) Revenue by Application (2017-2022) & (US$ Million)
Table 88. Latin America Tagrisso (Osimertinib) Revenue by Application (2023-2028) & (US$ Million)
Table 89. Latin America Tagrisso (Osimertinib) Sales by Country (2017-2022) & (K Pcs)
Table 90. Latin America Tagrisso (Osimertinib) Sales by Country (2023-2028) & (K Pcs)
Table 91. Latin America Tagrisso (Osimertinib) Revenue by Country (2017-2022) & (US$ Million)
Table 92. Latin America Tagrisso (Osimertinib) Revenue by Country (2023-2028) & (US$ Million)
Table 93. Middle East and Africa Tagrisso (Osimertinib) Sales by Type (2017-2022) & (K Pcs)
Table 94. Middle East and Africa Tagrisso (Osimertinib) Sales by Type (2023-2028) & (K Pcs)
Table 95. Middle East and Africa Tagrisso (Osimertinib) Revenue by Type (2017-2022) & (US$ Million)
Table 96. Middle East and Africa Tagrisso (Osimertinib) Revenue by Type (2023-2028) & (US$ Million)
Table 97. Middle East and Africa Tagrisso (Osimertinib) Sales by Application (2017-2022) & (K Pcs)
Table 98. Middle East and Africa Tagrisso (Osimertinib) Sales by Application (2023-2028) & (K Pcs)
Table 99. Middle East and Africa Tagrisso (Osimertinib) Revenue by Application (2017-2022) & (US$ Million)
Table 100. Middle East and Africa Tagrisso (Osimertinib) Revenue by Application (2023-2028) & (US$ Million)
Table 101. Middle East and Africa Tagrisso (Osimertinib) Sales by Country (2017-2022) & (K Pcs)
Table 102. Middle East and Africa Tagrisso (Osimertinib) Sales by Country (2023-2028) & (K Pcs)
Table 103. Middle East and Africa Tagrisso (Osimertinib) Revenue by Country (2017-2022) & (US$ Million)
Table 104. Middle East and Africa Tagrisso (Osimertinib) Revenue by Country (2023-2028) & (US$ Million)
Table 105. AstraZeneca Corporation Information
Table 106. AstraZeneca Description and Major Businesses
Table 107. AstraZeneca Tagrisso (Osimertinib) Sales (K Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2017-2022)
Table 108. AstraZeneca Tagrisso (Osimertinib) Product Model Numbers, Pictures, Descriptions and Specifications
Table 109. AstraZeneca Recent Developments
Table 110. Incepta Pharmaceuticals Ltd Corporation Information
Table 111. Incepta Pharmaceuticals Ltd Description and Major Businesses
Table 112. Incepta Pharmaceuticals Ltd Tagrisso (Osimertinib) Sales (K Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2017-2022)
Table 113. Incepta Pharmaceuticals Ltd Tagrisso (Osimertinib) Product Model Numbers, Pictures, Descriptions and Specifications
Table 114. Incepta Pharmaceuticals Ltd Recent Developments
Table 115. Lonza AG Corporation Information
Table 116. Lonza AG Description and Major Businesses
Table 117. Lonza AG Tagrisso (Osimertinib) Sales (K Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2017-2022)
Table 118. Lonza AG Tagrisso (Osimertinib) Product Model Numbers, Pictures, Descriptions and Specifications
Table 119. Lonza AG Recent Developments
Table 120. Everest Pharmaceuticals Corporation Information
Table 121. Everest Pharmaceuticals Description and Major Businesses
Table 122. Everest Pharmaceuticals Tagrisso (Osimertinib) Sales (K Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2017-2022)
Table 123. Everest Pharmaceuticals Tagrisso (Osimertinib) Product Model Numbers, Pictures, Descriptions and Specifications
Table 124. Everest Pharmaceuticals Recent Developments
Table 125. Beacon Pharmaceuticals Limited Corporation Information
Table 126. Beacon Pharmaceuticals Limited Description and Major Businesses
Table 127. Beacon Pharmaceuticals Limited Tagrisso (Osimertinib) Sales (K Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2017-2022)
Table 128. Beacon Pharmaceuticals Limited Tagrisso (Osimertinib) Product Model Numbers, Pictures, Descriptions and Specifications
Table 129. Beacon Pharmaceuticals Limited Recent Developments
Table 130. Drug International Limited Corporation Information
Table 131. Drug International Limited Description and Major Businesses
Table 132. Drug International Limited Tagrisso (Osimertinib) Sales (K Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2017-2022)
Table 133. Drug International Limited Tagrisso (Osimertinib) Product Model Numbers, Pictures, Descriptions and Specifications
Table 134. Drug International Limited Recent Developments
Table 135. Key Raw Materials Lists
Table 136. Raw Materials Key Suppliers Lists
Table 137. Tagrisso (Osimertinib) Distributors List
Table 138. Tagrisso (Osimertinib) Customers List
Table 139. Tagrisso (Osimertinib) Market Trends
Table 140. Tagrisso (Osimertinib) Market Drivers
Table 141. Tagrisso (Osimertinib) Market Challenges
Table 142. Tagrisso (Osimertinib) Market Restraints
Table 143. Research Programs/Design for This Report
Table 144. Key Data Information from Secondary Sources
Table 145. Key Data Information from Primary Sources
List of Figures
Figure 1. Tagrisso (Osimertinib) Product Picture
Figure 3. Global Tagrisso (Osimertinib) Market Share by Type in 2021 & 2028
Figure 3. 40 mg Product Picture
Figure 4. 80 mg Product Picture
Figure 5. Global Tagrisso (Osimertinib) Market Share by Application in 2021 & 2028
Figure 6. Locally Advanced NSCLC
Figure 7. Metastatic NSCLC
Figure 8. Other
Figure 9. Tagrisso (Osimertinib) Report Years Considered
Figure 10. Global Tagrisso (Osimertinib) Sales 2017-2028 (K Pcs)
Figure 11. Global Tagrisso (Osimertinib) Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 12. Global Tagrisso (Osimertinib) Revenue 2017-2028 (US$ Million)
Figure 13. Global Tagrisso (Osimertinib) Revenue Market Share by Region in Percentage: 2021 Versus 2028
Figure 14. Global Tagrisso (Osimertinib) Sales Market Share by Region (2017-2022)
Figure 15. Global Tagrisso (Osimertinib) Sales Market Share by Region (2023-2028)
Figure 16. North America Tagrisso (Osimertinib) Sales YoY (2017-2028) & (K Pcs)
Figure 17. North America Tagrisso (Osimertinib) Revenue YoY (2017-2028) & (US$ Million)
Figure 18. Europe Tagrisso (Osimertinib) Sales YoY (2017-2028) & (K Pcs)
Figure 19. Europe Tagrisso (Osimertinib) Revenue YoY (2017-2028) & (US$ Million)
Figure 20. Asia-Pacific Tagrisso (Osimertinib) Sales YoY (2017-2028) & (K Pcs)
Figure 21. Asia-Pacific Tagrisso (Osimertinib) Revenue YoY (2017-2028) & (US$ Million)
Figure 22. Latin America Tagrisso (Osimertinib) Sales YoY (2017-2028) & (K Pcs)
Figure 23. Latin America Tagrisso (Osimertinib) Revenue YoY (2017-2028) & (US$ Million)
Figure 24. Middle East & Africa Tagrisso (Osimertinib) Sales YoY (2017-2028) & (K Pcs)
Figure 25. Middle East & Africa Tagrisso (Osimertinib) Revenue YoY (2017-2028) & (US$ Million)
Figure 26. The Tagrisso (Osimertinib) Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
Figure 27. The Top 5 and 10 Largest Manufacturers of Tagrisso (Osimertinib) in the World: Market Share by Tagrisso (Osimertinib) Revenue in 2021
Figure 28. Global Tagrisso (Osimertinib) Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
Figure 29. Global Tagrisso (Osimertinib) Sales Market Share by Type (2017-2028)
Figure 30. Global Tagrisso (Osimertinib) Revenue Market Share by Type (2017-2028)
Figure 31. Global Tagrisso (Osimertinib) Sales Market Share by Application (2017-2028)
Figure 32. Global Tagrisso (Osimertinib) Revenue Market Share by Application (2017-2028)
Figure 33. North America Tagrisso (Osimertinib) Sales Market Share by Type (2017-2028)
Figure 34. North America Tagrisso (Osimertinib) Revenue Market Share by Type (2017-2028)
Figure 35. North America Tagrisso (Osimertinib) Sales Market Share by Application (2017-2028)
Figure 36. North America Tagrisso (Osimertinib) Revenue Market Share by Application (2017-2028)
Figure 37. North America Tagrisso (Osimertinib) Sales Share by Country (2017-2028)
Figure 38. North America Tagrisso (Osimertinib) Revenue Share by Country (2017-2028)
Figure 39. United States Tagrisso (Osimertinib) Revenue (2017-2028) & (US$ Million)
Figure 40. Canada Tagrisso (Osimertinib) Revenue (2017-2028) & (US$ Million)
Figure 41. Europe Tagrisso (Osimertinib) Sales Market Share by Type (2017-2028)
Figure 42. Europe Tagrisso (Osimertinib) Revenue Market Share by Type (2017-2028)
Figure 43. Europe Tagrisso (Osimertinib) Sales Market Share by Application (2017-2028)
Figure 44. Europe Tagrisso (Osimertinib) Revenue Market Share by Application (2017-2028)
Figure 45. Europe Tagrisso (Osimertinib) Sales Share by Country (2017-2028)
Figure 46. Europe Tagrisso (Osimertinib) Revenue Share by Country (2017-2028)
Figure 47. Germany Tagrisso (Osimertinib) Revenue (2017-2028) & (US$ Million)
Figure 48. France Tagrisso (Osimertinib) Revenue (2017-2028) & (US$ Million)
Figure 49. U.K. Tagrisso (Osimertinib) Revenue (2017-2028) & (US$ Million)
Figure 50. Italy Tagrisso (Osimertinib) Revenue (2017-2028) & (US$ Million)
Figure 51. Russia Tagrisso (Osimertinib) Revenue (2017-2028) & (US$ Million)
Figure 52. Asia Pacific Tagrisso (Osimertinib) Sales Market Share by Type (2017-2028)
Figure 53. Asia Pacific Tagrisso (Osimertinib) Revenue Market Share by Type (2017-2028)
Figure 54. Asia Pacific Tagrisso (Osimertinib) Sales Market Share by Application (2017-2028)
Figure 55. Asia Pacific Tagrisso (Osimertinib) Revenue Market Share by Application (2017-2028)
Figure 56. Asia Pacific Tagrisso (Osimertinib) Sales Share by Region (2017-2028)
Figure 57. Asia Pacific Tagrisso (Osimertinib) Revenue Share by Region (2017-2028)
Figure 58. China Tagrisso (Osimertinib) Revenue (2017-2028) & (US$ Million)
Figure 59. Japan Tagrisso (Osimertinib) Revenue (2017-2028) & (US$ Million)
Figure 60. South Korea Tagrisso (Osimertinib) Revenue (2017-2028) & (US$ Million)
Figure 61. India Tagrisso (Osimertinib) Revenue (2017-2028) & (US$ Million)
Figure 62. Australia Tagrisso (Osimertinib) Revenue (2017-2028) & (US$ Million)
Figure 63. China Taiwan Tagrisso (Osimertinib) Revenue (2017-2028) & (US$ Million)
Figure 64. Indonesia Tagrisso (Osimertinib) Revenue (2017-2028) & (US$ Million)
Figure 65. Thailand Tagrisso (Osimertinib) Revenue (2017-2028) & (US$ Million)
Figure 66. Malaysia Tagrisso (Osimertinib) Revenue (2017-2028) & (US$ Million)
Figure 67. Latin America Tagrisso (Osimertinib) Sales Market Share by Type (2017-2028)
Figure 68. Latin America Tagrisso (Osimertinib) Revenue Market Share by Type (2017-2028)
Figure 69. Latin America Tagrisso (Osimertinib) Sales Market Share by Application (2017-2028)
Figure 70. Latin America Tagrisso (Osimertinib) Revenue Market Share by Application (2017-2028)
Figure 71. Latin America Tagrisso (Osimertinib) Sales Share by Country (2017-2028)
Figure 72. Latin America Tagrisso (Osimertinib) Revenue Share by Country (2017-2028)
Figure 73. Mexico Tagrisso (Osimertinib) Revenue (2017-2028) & (US$ Million)
Figure 74. Brazil Tagrisso (Osimertinib) Revenue (2017-2028) & (US$ Million)
Figure 75. Argentina Tagrisso (Osimertinib) Revenue (2017-2028) & (US$ Million)
Figure 76. Colombia Tagrisso (Osimertinib) Revenue (2017-2028) & (US$ Million)
Figure 77. Middle East and Africa Tagrisso (Osimertinib) Sales Market Share by Type (2017-2028)
Figure 78. Middle East and Africa Tagrisso (Osimertinib) Revenue Market Share by Type (2017-2028)
Figure 79. Middle East and Africa Tagrisso (Osimertinib) Sales Market Share by Application (2017-2028)
Figure 80. Middle East and Africa Tagrisso (Osimertinib) Revenue Market Share by Application (2017-2028)
Figure 81. Middle East and Africa Tagrisso (Osimertinib) Sales Share by Country (2017-2028)
Figure 82. Middle East and Africa Tagrisso (Osimertinib) Revenue Share by Country (2017-2028)
Figure 83. Turkey Tagrisso (Osimertinib) Revenue (2017-2028) & (US$ Million)
Figure 84. Saudi Arabia Tagrisso (Osimertinib) Revenue (2017-2028) & (US$ Million)
Figure 85. UAE Tagrisso (Osimertinib) Revenue (2017-2028) & (US$ Million)
Figure 86. Tagrisso (Osimertinib) Value Chain
Figure 87. Tagrisso (Osimertinib) Production Process
Figure 88. Channels of Distribution
Figure 89. Distributors Profiles
Figure 90. Bottom-up and Top-down Approaches for This Report
Figure 91. Data Triangulation
Figure 92. Key Executives Interviewed

---